indium in-111 Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem

Active Ingredient History

NOW
  • Now
Indium In-111 pentetate disodium is a radioactive diagnostic indicated for use in radionuclide cisternography. Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column. Indium In 111 pentetate ( 111In-DTPA) is indicated as an imaging agent in cisternography to study the flow of cerebrospinal fluid (CSF) in the brain, to diagnose abnormalities in CSF circulation, to assess and help localize the site of CSF leakage, and to test the patency of or localize blocks in CSF shunts.   NCATS

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

111in-bevacizumab | (111)indium chloride | 111indium trichloride | (113)indium chloride | indiclor | indium | indium-111 chloride | indium (111in) chloride injection | indium chloride | indium chloride (111incl3) | indium chloride in-111 | indium chloride (incl3) | indium in-111 | indium in 111 chloride | indium in-111 chloride | indium in-111 chloride solution | indium in 111m chloride | indium in-111m chloride | indium trichloride | indium trichloride, 111in-labeled | indium trichloride (113) | indium trichloride, 113in-labeled

Organizations (4)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (4)

Approved Indications (4)


 

Arachnoid Cysts (approved 1982)

Hydrocephalus (approved 1982)

Radioimmunodetection (approved 1994)

Syringomyelia (approved 1982)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Overview

  • Highest Phase: N/A
  • # of Trials: 1
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue